[Federal Register Volume 62, Number 51 (Monday, March 17, 1997)]
[Notices]
[Pages 12658-12659]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6627]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Arthritis and Musculoskeletal and Skin Diseases 
Special Emphasis Panel (SEP) meeting:

    Name of SEP: Gene Therapy for Epidermolysis Bullosa.
    Date: April 4, 1997.
    Time: 8:30 a.m.-adjournment.
    Place: Holiday Inn Bethesda, 8120 Wisconsin Avenue, Bethesda, 
Maryland 20814.

[[Page 12659]]

    Contact Person: Tommy L. Broadwater, Ph.D., Chief, Grants Review 
Branch, Natcher Building, 45 Center Drive, Rm 5AS-25U, Bethesda, 
Maryland 20892-6500, Telephone: 301-594-4952.
    Purpose/Agenda: To evaluate and review a research grant 
application.
    The meeting will be closed in accordance with the provisions set 
forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The 
discussion of this application could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
application, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Nos. [93.846, 
Project Grants in Arthritis, Musculoskeletal and Skin Diseases 
Research], National Institutes of Health, HHS)

    Dated: March 12, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-6627 Filed 3-14-97; 8:45 am]
BILLING CODE 4140-01-M